290 related articles for article (PubMed ID: 35812667)
21. Identification of miR-199a-5p in serum as noninvasive biomarkers for detecting and monitoring osteosarcoma.
Zhou G; Lu M; Chen J; Li C; Zhang J; Chen J; Shi X; Wu S
Tumour Biol; 2015 Nov; 36(11):8845-52. PubMed ID: 26069101
[TBL] [Abstract][Full Text] [Related]
22. Circulating MicroRNAs as Quantitative Biomarkers for Diagnosis and Prognosis of Uveal Melanoma.
Zhou WD; Shao L; Dong L; Zhang RH; Li YF; Li HY; Wu HT; Shi XH; Wei WB
Front Oncol; 2022; 12():854253. PubMed ID: 35433428
[TBL] [Abstract][Full Text] [Related]
23. Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists.
Garabet L; Ghanima W; Rangberg A; Teruel-Montoya R; Martinez C; Lozano ML; Nystrand CF; Bussel JB; Sandset PM; Jonassen CM
Platelets; 2020; 31(2):198-205. PubMed ID: 30885035
[TBL] [Abstract][Full Text] [Related]
24. Downregulation of serum exosomal miR-150-5p is associated with poor prognosis in patients with colorectal cancer.
Zou SL; Chen YL; Ge ZZ; Qu YY; Cao Y; Kang ZX
Cancer Biomark; 2019; 26(1):69-77. PubMed ID: 31306108
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA expression profile in serum reveals novel diagnostic biomarkers for endometrial cancer.
Fan X; Zou X; Liu C; Cheng W; Zhang S; Geng X; Zhu W
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34076696
[TBL] [Abstract][Full Text] [Related]
26. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X
World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818
[TBL] [Abstract][Full Text] [Related]
27. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
28. Urinary Exosomal miRNAs as biomarkers of bladder Cancer and experimental verification of mechanism of miR-93-5p in bladder Cancer.
Lin H; Shi X; Li H; Hui J; Liu R; Chen Z; Lu Y; Tan W
BMC Cancer; 2021 Dec; 21(1):1293. PubMed ID: 34861847
[TBL] [Abstract][Full Text] [Related]
29. Circulating miR-141-3p, miR-143-3p and miR-200c-3p are differentially expressed in colorectal cancer and advanced adenomas.
Ardila HJ; Sanabria-Salas MC; Meneses X; Rios R; Huertas-Salgado A; Serrano ML
Mol Clin Oncol; 2019 Aug; 11(2):201-207. PubMed ID: 31316774
[TBL] [Abstract][Full Text] [Related]
30. Circulating serum miR-1246 and miR-1229 as diagnostic biomarkers in colorectal carcinoma.
Rafiee R; Razmara E; Motavaf M; Mossahebi-Mohammadi M; Khajehsharifi S; Rouhollah F; Babashah S
J Cancer Res Ther; 2022 Dec; 18(Supplement):S383-S390. PubMed ID: 36510992
[TBL] [Abstract][Full Text] [Related]
31. Discovery of extracellular vesicle-delivered miR-185-5p in the plasma of patients as an indicator for advanced adenoma and colorectal cancer.
Shi YJ; Fang YX; Tian TG; Chen WP; Sun Q; Guo FQ; Gong PQ; Li CM; Wang H; Hu ZQ; Li XX
J Transl Med; 2023 Jun; 21(1):421. PubMed ID: 37386465
[TBL] [Abstract][Full Text] [Related]
32. Expression levels of miR-143-3p and -424-5p in colorectal cancer and their clinical significance.
Sahami-Fard MH; Kheirandish S; Sheikhha MH
Cancer Biomark; 2019; 24(3):291-297. PubMed ID: 30883340
[TBL] [Abstract][Full Text] [Related]
33. Serum miR-21, miR-29a, and miR-125b Are Promising Biomarkers for the Early Detection of Colorectal Neoplasia.
Yamada A; Horimatsu T; Okugawa Y; Nishida N; Honjo H; Ida H; Kou T; Kusaka T; Sasaki Y; Yagi M; Higurashi T; Yukawa N; Amanuma Y; Kikuchi O; Muto M; Ueno Y; Nakajima A; Chiba T; Boland CR; Goel A
Clin Cancer Res; 2015 Sep; 21(18):4234-42. PubMed ID: 26038573
[TBL] [Abstract][Full Text] [Related]
34. Study on identification of a three-microRNA panel in serum for diagnosing neonatal early onset sepsis.
Zhao Y; Lu C; Zhu R; Hu X
J Matern Fetal Neonatal Med; 2023 Dec; 36(2):2280527. PubMed ID: 37968923
[TBL] [Abstract][Full Text] [Related]
35. Plasma miRNAs as potential biomarkers for schizophrenia in a Jordanian cohort.
Shboul M; Bani Domi A; Abu Zahra A; Khasawneh AG; Darweesh R
Noncoding RNA Res; 2024 Jun; 9(2):350-358. PubMed ID: 38511065
[TBL] [Abstract][Full Text] [Related]
36. Molecular detection of exosomal miRNAs of blood serum for prognosis of colorectal cancer.
Bakhsh T; Alhazmi S; Farsi A; Yusuf AS; Alharthi A; Qahl SH; Alghamdi MA; Alzahrani FA; Elgaddar OH; Ibrahim MA; Bahieldin A
Sci Rep; 2024 Apr; 14(1):8902. PubMed ID: 38632250
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive microRNA analysis identifies miR-24 and miR-125a-5p as plasma biomarkers for rheumatoid arthritis.
Murata K; Furu M; Yoshitomi H; Ishikawa M; Shibuya H; Hashimoto M; Imura Y; Fujii T; Ito H; Mimori T; Matsuda S
PLoS One; 2013; 8(7):e69118. PubMed ID: 23874885
[TBL] [Abstract][Full Text] [Related]
38. A four serum-miRNA panel serves as a potential diagnostic biomarker of osteosarcoma.
Huang C; Wang Q; Ma S; Sun Y; Vadamootoo AS; Jin C
Int J Clin Oncol; 2019 Aug; 24(8):976-982. PubMed ID: 31111286
[TBL] [Abstract][Full Text] [Related]
39. Identification of stool miR-135b-5p as a non-invasive diaognostic biomarker in later tumor stage of colorectal cancer.
Li L; Wang A; Cai M; Tong M; Chen F; Huang L
Life Sci; 2020 Nov; 260():118417. PubMed ID: 32931801
[TBL] [Abstract][Full Text] [Related]
40. Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
Duran-Sanchon S; Moreno L; Augé JM; Serra-Burriel M; Cuatrecasas M; Moreira L; Martín A; Serradesanferm A; Pozo À; Costa R; Lacy A; Pellisé M; Lozano JJ; Gironella M; Castells A
Gastroenterology; 2020 Mar; 158(4):947-957.e4. PubMed ID: 31622624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
